FDAnews
www.fdanews.com/articles/96628-canopus-biopharma-inc-8217-s-statc-drug-shows-superior-results-for-treatment-of-avian-flu-and-other-influenzas

Canopus BioPharma, Inc.’s StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas

August 1, 2007

Canopus BioPharma, Inc, a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, bio-terrorism, cancer, and addiction, announced today groundbreaking results in animal trials for its drug candidate StatC against Avian Flu, Spanish Flu and Hong Kong Flu strains.
BioSpace